ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,300Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 559

$472K Total Retail Price of All Prescriptions

Rank: 40 out of 559

454 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,025 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 376 301 1 2
LISINOPRIL 288 239 2 1
SIMVASTATIN 245 210 3 3
HYDROCHLOROTHIAZIDE 208 168 4 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 201 167 5 18
OMEPRAZOLE 177 103 6 4
GABAPENTIN 150 84 7 9
METOPROLOL TARTRATE 149 130 8 12
LOVASTATIN 147 112 9 10
METFORMIN HCL 142 101 10 5
FLUTICASONE PROPIONATE 116 75 11 22
TRAMADOL HCL 115 60 12 27
ATORVASTATIN CALCIUM 115 53 12 20
AMLODIPINE BESYLATE 112 87 14 6
ZOLPIDEM TARTRATE 110 53 15 17
METOPROLOL SUCCINATE 107 100 16 16
ADVAIR DISKUS 102 84 17 46
HYDROCODONE-ACETAMINOPHEN 100 52 S3 18 7
FUROSEMIDE 96 60 19 11
RANITIDINE HCL 93 65 20 26
LOSARTAN POTASSIUM 90 88 21 14
PANTOPRAZOLE SODIUM 79 64 22 41
OXYBUTYNIN CHLORIDE 78 50 23 62
CRESTOR 76 63 24 33
LOSARTAN-HYDROCHLOROTHIAZIDE 75 71 25 52
OXYCODONE HCL 70 21 S2 26 32
IBUPROFEN 69 50 27 30
SPIRIVA 69 56 27 67
TRAZODONE HCL 67 19 29 28
ALENDRONATE SODIUM 66 44 30 13
PROAIR HFA 65 15 31 29
ATENOLOL 65 56 31 15
SERTRALINE HCL 56 47 33 19
CYCLOBENZAPRINE HCL 55 14 R 34 54
FELODIPINE ER 54 54 35 72
AMITRIPTYLINE HCL 54 20 R 35 58
DONEPEZIL HCL 53 52 37 36
JANUVIA 50 48 38 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.